According to Altimmune's latest financial reports the company's current earnings are $0.02 Million USD. a decrease over its 2023 earnings that were of -$88.45 Million USD. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2024 | -$95.06 Million | 7.48% |
2023 | -$88.45 Million | 4.17% |
2022 | -$84.91 Million | -12.55% |
2021 | -$97.1 Million | 78.27% |
2020 | -$54.47 Million | 164.65% |
2019 | -$20.58 Million | -54.59% |
2018 | -$45.33 Million | -12.95% |
2017 | -$52.07 Million | -164.04% |
2016 | $81.3 M | -2506.1% |
2015 | -$3.38 Million | -65.85% |
2014 | -$9.9 Million | -15.12% |
2013 | -$11.66 Million | 146.72% |
2012 | -$4.73 Million | -16.07% |
2011 | -$5.63 Million | -76.1% |
2010 | -$23.56 Million | -8.89% |
2009 | -$25.86 Million | 31.17% |
2008 | -$19.71 Million | 549.91% |
2007 | -$3.04 Million | 7.52% |
2006 | -$2.83 Million |